AstraZeneca Reports a Strong 7% Revenue Growth to $13.6 Billion in Q1 2025
AstraZeneca PLC announced a 7% revenue increase to $13.6 billion in Q1 2025, with product sales up by 6%. The company forecasts continued growth, aiming for $80 billion in total re...